American Pharmacogenomics Association (APGxA)
The American Pharmacogenomics Association (APGxA) provides an exclusive platform for PGx leaders to connect, collaborate, and leverage the commercial opportunities within this rapidly evolving field. APGxA members gain access to invaluable resources, insights, and networking opportunities that drive business growth and success. Join APGxA and position your organization at the forefront of personalized medicine.
Sign up for our Community Pop-Up PGx Screening!
Get the Right Meds for YOU: A Year-Long Ten City Tour of DNA Medication Screening
The American Pharmacogenomics Association (APGxA) is a driving force in the burgeoning field of pharmacogenomics, bridging the gap between genetic insights and practical healthcare solutions. APGxA serves as a central hub for industry professionals, fostering collaboration, education, and research to accelerate the integration of pharmacogenomics into mainstream clinical practice.
Beyond its core activities, APGxA actively engages in public outreach and advocacy, partnering with key stakeholders to champion the adoption of pharmacogenomic testing. By equipping healthcare providers and patients with the knowledge and tools to interpret genetic data, APGxA empowers informed decision-making and paves the way for personalized treatment plans.
With its additional International division, APGxA extends its reach globally, promoting awareness and facilitating the adoption of pharmacogenomics worldwide. Through its multifaceted efforts, APGxA is catalyzing the transformation of healthcare, enabling more personalized, effective, and safer drug therapies tailored to each patient’s unique genetic profile.
What we have to offer…
Membership Benefits
ADVOCACY, not mentioned to the list on the right because there is simply too much to say about it.
The American Pharmacogenomics Association (APGxA) is a catalyst for business growth in the pharmacogenomics sector, providing invaluable support to a wide range of professionals, from labs and pharmacists to researchers and billing specialists. APGxA equips its members with the knowledge, resources, and networking opportunities needed to thrive in this rapidly evolving field. By fostering collaboration, innovation, and education, APGxA is driving the growth of the pharmacogenomics market, creating new business opportunities, and ultimately improving patient care through personalized medicine.
The American Pharmacogenomics Association proudly partners with the Western New England University College of Pharmacy’s Master of Science in Pharmacogenomics program. Taught in the cutting-edge facilities of the Center for the Science and Pharmacy, the curriculum equips students for careers in research, the pharmaceutical sector, regulatory bodies, genetic testing labs, or clinical environments. This program offers a comprehensive foundation for those seeking to advance in the field of pharmacogenomics.
COURSE
PGx Education
Our mini course is now available! Pharmacogenomics: Understanding Genetic Influences on Drug Response.
This course on Pharmacogenomics delves into the intricate relationship between genetic variations and drug responses, tackling the pressing issue of optimizing medication efficacy and minimizing adverse reactions. Get more information here:
Join our monthly PGx Coffee Talks! Casual and fun chit chat about industry happenings!
LIVE Webinar
Q2 Date TBA
Next quarter webinar information will be coming soon!
Date: TBA
Time: 8:00AM PST
Information on the next webinar will be here soon!
And it will remain our primary goal.
The American Pharmacogenomics Association (APGxA) prioritizes education as a cornerstone of its mission. By empowering patients and healthcare professionals with knowledge about PGx testing, APGxA strives to bridge the gap between scientific advancements and real-world application. individuals to make informed decisions about their medications, while also equipping healthcare providers with the tools to integrate PGx into personalized treatment plans. Ultimately, APGxA’s educational initiatives pave the way for a future of optimized medication management and improved patient outcomes.
Order a PGx Test DIRECT 📪
The APGxA Precision Medication Test (Pharmacogenomics) is a simple and convenient, at-home test kit that equips you and your provider with the information necessary to determine the right medication selection and dosing based on your unique genetic makeup. The test delves into therapeutic areas such as Cardiovascular, Psychiatry, Gastroenterology, Immunology, Endocrinology, and Pain Management.
Order a Precision Nutrition Test DIRECT 🥝
Our bodies are as unique as our personalities, and standard nutrition guidelines simply can’t cater to the individual nuances of our genetic makeup. The APGxA Precision Nutrition Test (Nutrigenomics), is the future of health and wellness, ensuring that every meal and lifestyle choice you make isoptimized for your fitness levels, health, and overall well-being. With insights from your report, you’ll be empowered to make sustainable changes.
legislation
We support Bill H.R. 6875 – 17th Congress (2022)
Sponsored by Representative, Eric Swalwell, this bill sets out requirements and activities to address adverse drug events, including using pharmacogenomic testing to prevent them. (Pharmacogenomic testing uses a patient’s genetic information to help determine the safety, efficacy, and dosage of medications for treatments.)
A proud handful of our member companies…
